JP2018510962A5 - - Google Patents

Download PDF

Info

Publication number
JP2018510962A5
JP2018510962A5 JP2018503836A JP2018503836A JP2018510962A5 JP 2018510962 A5 JP2018510962 A5 JP 2018510962A5 JP 2018503836 A JP2018503836 A JP 2018503836A JP 2018503836 A JP2018503836 A JP 2018503836A JP 2018510962 A5 JP2018510962 A5 JP 2018510962A5
Authority
JP
Japan
Prior art keywords
mixture
eye
bixin
carbonyldiimidazole
dmf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018503836A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018510962A (ja
JP6847091B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2016/051960 external-priority patent/WO2016162809A1/en
Publication of JP2018510962A publication Critical patent/JP2018510962A/ja
Publication of JP2018510962A5 publication Critical patent/JP2018510962A5/ja
Application granted granted Critical
Publication of JP6847091B2 publication Critical patent/JP6847091B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018503836A 2015-04-07 2016-04-07 グリコサミノグリカンエステル、それらを調製する方法および眼科用途のための製剤におけるそれらの使用 Expired - Fee Related JP6847091B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITFI2015A000102 2015-04-07
ITFI20150102 2015-04-07
PCT/IB2016/051960 WO2016162809A1 (en) 2015-04-07 2016-04-07 Glycosaminoglycan esters, processes for their preparation and their use in formulations for ophthalmic use

Publications (3)

Publication Number Publication Date
JP2018510962A JP2018510962A (ja) 2018-04-19
JP2018510962A5 true JP2018510962A5 (cg-RX-API-DMAC10.html) 2019-05-16
JP6847091B2 JP6847091B2 (ja) 2021-03-24

Family

ID=53719816

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018503836A Expired - Fee Related JP6847091B2 (ja) 2015-04-07 2016-04-07 グリコサミノグリカンエステル、それらを調製する方法および眼科用途のための製剤におけるそれらの使用

Country Status (12)

Country Link
US (1) US10328097B2 (cg-RX-API-DMAC10.html)
EP (1) EP3280396B1 (cg-RX-API-DMAC10.html)
JP (1) JP6847091B2 (cg-RX-API-DMAC10.html)
KR (1) KR20180002674A (cg-RX-API-DMAC10.html)
CN (1) CN107636020A (cg-RX-API-DMAC10.html)
AU (1) AU2016244391B2 (cg-RX-API-DMAC10.html)
BR (1) BR112017021608A2 (cg-RX-API-DMAC10.html)
CA (1) CA2981861A1 (cg-RX-API-DMAC10.html)
ES (1) ES2888648T3 (cg-RX-API-DMAC10.html)
MA (1) MA41912A (cg-RX-API-DMAC10.html)
RU (1) RU2726192C2 (cg-RX-API-DMAC10.html)
WO (1) WO2016162809A1 (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202000012535A1 (it) * 2020-05-27 2021-11-27 Stefano Colombo Composizione oftalmica a base di acido ialuronico per la protezione dai danni causati dall’inquinamento ambientale
WO2022094695A1 (en) 2020-11-03 2022-05-12 Institut National De La Recherche Scientifique A method and a system for compressed ultrafast tomographic imaging
CN116284495B (zh) * 2023-03-20 2024-08-30 润辉生物技术(威海)有限公司 全反式维甲酸低分子透明质酸酯衍生物及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4851521A (en) * 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
IT1281877B1 (it) * 1995-05-10 1998-03-03 Fidia Advanced Biopolymers Srl Sali di metalli pesanti di succinil derivati dell'acido ialuronico e loro impiego come potenziali agenti terapeutici
ITTS20010017A1 (it) * 2001-07-17 2003-01-17 Ct Ricerche Polytech Soc Coop Esteri polisaccaridici di acido retinoico.
ITMI20022745A1 (it) * 2002-12-23 2004-06-24 Coimex Scrl United Companies Esteri misti dell'acido ialuronico ad attivita' citostatica e prodifferenziante e procedimento per la loro produzione.
ITMI20030043A1 (it) * 2003-01-14 2004-07-15 Coimex S C R L United Companies Uso di esteri retinoici dell'acido ialuronico in cellule
WO2005077176A1 (en) * 2004-02-11 2005-08-25 The Trustees Of Columbia University In The City Of New York Anthocyanin compounds and methods of use thereof
ITMI20040347A1 (it) * 2004-02-26 2004-05-26 Pharma Medical Ltd Nuovo farmaco di associazione
US20070207116A1 (en) * 2006-03-01 2007-09-06 Brown David C Antioxidant compositions for the eye
ITMI20062134A1 (it) * 2006-11-08 2008-05-09 Cbb Net S A Preparaziobne di esteri della diacereina con acido ialuronico e loro formulazioni per l'impiego farmaceutico
US8865685B2 (en) * 2011-06-30 2014-10-21 Johnson & Johnson Vision Care, Inc. Esters for treatment of ocular inflammatory conditions
CA2886115A1 (en) * 2012-10-02 2014-04-10 Allergan, Inc. Dermal filler hydrogels with vitamin a/cyclodextrin inclusion complexes

Similar Documents

Publication Publication Date Title
EA201890618A1 (ru) Способы и композиции для лечения состояний, ассоциированных с аномальными воспалительными ответами
WO2011159550A3 (en) Lysophosphatidic acid receptor antagonist and uses thereof
EA201390840A1 (ru) Полициклический lpaантагонист и его применение
WO2013066839A3 (en) Compounds and methods
IN2012DE00337A (cg-RX-API-DMAC10.html)
MD4673B1 (ro) Letermovir amorf şi forme preparative farmaceutice solide ale acestuia pentru administrare orală
JP2017535521A5 (cg-RX-API-DMAC10.html)
EA202090259A1 (ru) Новые гетероариламидные производные как селективные ингибиторы гистондеацетилаз 1 и/или 2 (hdac1-2)
JP2015078201A5 (cg-RX-API-DMAC10.html)
WO2015104292A3 (en) Compounds for use in treating or preventing cancerous diseases
MX388300B (es) Proceso para la preparación de derivados de ácidos biliares de sulfonil carbamato
JP2015511957A5 (cg-RX-API-DMAC10.html)
EA202090500A1 (ru) Кристаллические формы иммуномодуляторов
RU2019119405A (ru) Лиофилизированные фармацевтические композиции далбаванцина
HK1203394A1 (en) Ghrelin receptor agonists for the treatment of achlorhydria
HRP20220544T1 (hr) Nove soli i polimorfi scy-078
ES2791295T3 (es) Procedimiento para purificar ácido ferúlico y/o sales del mismo
CL2020001420A1 (es) Procedimiento para la preparación de (3s)-3-(4-cloro-3-{[(2s,3r)-2-(4-clorofenil)-4,4,4-trifluor-3-metilbutanoil] amino}fenil)-3-ácido ciclopropilpropanoico y su forma cristalina para uso como principio activo farmacéutico.
PH12012501349A1 (en) Dp2 antagonist and uses thereof
AR081267A1 (es) Procedimiento de obtencion de la forma cristalina a del febuxostat
HRP20220234T1 (hr) Kristalni oblici
TW201513854A (zh) 用於馬的炎症治療之製劑
AR079299A1 (es) Mejora de los procesos para la preparacion de granulos solubles de las sales de los acidos carboxilicos que contienen piridina
CN103550755B (zh) 一种氟苯尼考硫酸粘菌素可溶性粉及其制备方法
JP2017008001A5 (cg-RX-API-DMAC10.html)